May 25, 2021
14:00 GMT / 15:00 CEST / 9:00 EST
Experience with genome editing has revealed a number of pitfalls and missteps that can happen along the way. Join our experts in a compelling discussion about what you should know before tackling a genome editing project. They raise important questions, highlight what to be aware of, and provide best practices to ensure your edits worked as intended.
Benjamin Schmid, Research Scientist, Cellular Engineering and Disease Models, Bioneer A/S
Bioneer A/S has been working with different genome editing techniques for almost 10 years and has been through the evolution of gene editing. During the last 5 years, CRISPR/Cas9 has been the gene editing tool of choice. Dr. Benjamin Schmid will present lessons learnt and key quality control steps during a gene editing project.
Dr. Peter Mouritzen, VP Application & Market Development, Samplix
Enabling precise genetic modifications, CRISPR-based editing techniques have redefined how we explore the genome and may allow engineering tomorrow’s medicines or better crops. Validating CRISPR edits, however, is not that straightforward. Commonly used methods have missed critical unintended alterations. Dr. Peter Mouritzen discusses an expanded quality control for unintended modifications by covering a larger region around the gene edit and demonstrates this with examples to establish a comprehensive validation strategy.
ContactMileparken 282730 HerlevDenmark
email@example.comPhone: (+45) 82 30 45 00
CVR 32 30 93 21
Connect with us
2019 Samplix® ApS. All rights reserved. For Research Use Only. Not for use in diagnostic procedures.